Literature DB >> 20373983

Family history of thyroid cancer and the risk of differentiated thyroid cancer in French polynesia.

Pauline Brindel1, Françoise Doyon, Catherine Bourgain, Frédérique Rachédi, Jean-Louis Boissin, Joseph Sebbag, Larrys Shan, Frédérique Bost-Bezeaud, Patrice Petitdidier, John Paoaafaite, Joseph Teuri, Florent de Vathaire.   

Abstract

BACKGROUND: Differentiated thyroid carcinoma is considered to be the nonhereditary cancer for which familial inheritance is the highest. To date, no familial aggregation analysis of this cancer has been performed in Maohi populations, which exhibit a very high incidence rate. Therefore, we evaluate the risk of differentiated thyroid cancer associated with a family history of thyroid cancer in natives of French Polynesia.
METHODS: We investigated thyroid cancer incidence in the first-degree relatives of 225 cases of differentiated thyroid carcinomas diagnosed between 1979 and 2004 in patients born in French Polynesia, and 368 randomly selected population controls matched for sex and age, born and residing in French Polynesia. All but five thyroid cancers declared among relatives were validated.
RESULTS: Twenty-four cases declared a family history of thyroid cancer, when compared with 11 controls. Individuals with an affected first-degree relative had a 4.5-fold (95% confidence interval [CI], 1.9-10.6) increased risk of differentiated thyroid cancer. This odds ratio (OR) was not significantly higher when a male first-degree relative was affected (OR, 10.0; 95% CI, 1.3-74.8) compared with a female (OR, 4.0; 95% CI, 1.5-10.3) and was not different for patients who had a nonaggressive thyroid microcarcinoma (OR, 3.5; 95% CI, 0.6-16.4) than those who had a larger cancer (OR, 6.0; 95% CI, 1.8-20.5). This OR was borderline significantly (p, 0.07) higher in Maohis (OR, 11.0; 95% CI, 2.4-48.8) than in individuals of mixed origin (OR, 2.1; 95% CI, 0.8-5.9).
CONCLUSION: Our study shows that the familial inheritance of differentiated thyroid cancer is particularly high in Maohi populations.

Entities:  

Mesh:

Year:  2010        PMID: 20373983     DOI: 10.1089/thy.2009.0350

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

Review 1.  Nuclear weapons tests and environmental consequences: a global perspective.

Authors:  Remus Prăvălie
Journal:  Ambio       Date:  2014-02-22       Impact factor: 5.129

2.  Family history of cancer and risk of sporadic differentiated thyroid carcinoma.

Authors:  Li Xu; Guojun Li; Qingyi Wei; Adel K El-Naggar; Erich M Sturgis
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

3.  Thyroid cancer following nuclear tests in French Polynesia.

Authors:  F de Vathaire; V Drozdovitch; P Brindel; F Rachedi; J-L Boissin; J Sebbag; L Shan; F Bost-Bezeaud; P Petitdidier; J Paoaafaite; J Teuri; J Iltis; A Bouville; E Cardis; C Hill; F Doyon
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

4.  Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.

Authors:  Stéphane Maillard; Francesca Damiola; Enora Clero; Maroulio Pertesi; Nivonirina Robinot; Frédérique Rachédi; Jean-Louis Boissin; Joseph Sebbag; Larrys Shan; Frédérique Bost-Bezeaud; Patrick Petitdidier; Françoise Doyon; Constance Xhaard; Carole Rubino; Hélène Blanché; Vladimir Drozdovitch; Fabienne Lesueur; Florent de Vathaire
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

Review 5.  Association of rs6983267 Polymorphism and Thyroid Cancer Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Jingdong Li; Xiaofei Wang; Jiahong Dong
Journal:  Med Sci Monit       Date:  2016-06-02

6.  Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway.

Authors:  Zheng-Cai Jiang; Xiao-Jun Chen; Qi Zhou; Xiao-Hua Gong; Xiong Chen; Wen-Jun Wu
Journal:  Int J Oncol       Date:  2019-05-29       Impact factor: 5.650

7.  Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.

Authors:  Alina V Brenner; Gila Neta; Erich M Sturgis; Ruth M Pfeiffer; Amy Hutchinson; Meredith Yeager; Li Xu; Cindy Zhou; William Wheeler; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.